<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230429058020N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-07</date_registration>
      <primary_sponsor>Faculty of Medicine, Islamic Azad University of Medical Sciences, Tehran</primary_sponsor>
      <public_title>The effect of foot exercises on the pain of diabetic foot neuropathy</public_title>
      <acronym></acronym>
      <scientific_title>Investigating The effect of foot exercise on the pain of diabetic foot neuropathy in the selected medical center affiliated to Tehran University of Medical Sciences in 2023</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-05-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69830</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Other, Purpose: Supportive, Randomization description: Sampling of this research is random and gradual, that is, qualified people will enter the research after knowing the steps and objectives of the research and completing the consent form if they have the conditions to enter and if they do not have the conditions to not enter the research. This sampling is gradual, that is, it is done during at least one week. Eligible samples will be divided into two control and test groups by simple random sampling method. Out of the clients on odd days, they are in the intervention group and the clients on even days are in the control group, Blinding description: The number of samples for the intervention group was 30 people and for the control group 30 people, which were randomly selected from among the clients. Out of the clients on odd days, they are in the intervention group and the clients on even days are in the control group. And in this way, people do not know that they are in the intervention or control group, and the researcher knows about the condition of the participants.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Diabetic neuropathy pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention group, after selecting the qualified samples and explaining about the research stages, the required concepts and the benefits of leg exercises and how to perform them, the patient's consent is obtained, and then after obtaining a written consent, in the same session, the personal information form and the questionnaire A summary of the pain intensity will be provided to the patient and after going through the above steps, for 12 consecutive weeks and three days a week between 8:00 and 13:00, one training set with 8-10 repetitions per hour individually for each person, in the bed. The patient performs leg exercises in the presence of the researcher, which will take 5-10 minutes. At home, these exercises should be performed 2-3 times a day, 10 repetitions each time, and the number of times will gradually increase, and the patients will be monitored and guided by phone calls at least once a week.Before and after performing leg exercises (before the intervention and then 12 weeks later), the patient's diabetes indicators (glycosylated hemoglobin, fasting blood sugar, blood sugar 2 hours after a meal and body mass index) are measured and recorded. Also, before and after the completion of 12 weeks, the patient's pain level is measured by a questionnaire. Intervention 2: Control group: In the control group, the patient's consent will be obtained after the necessary explanations about the research steps. Then, in the same meeting, the personal information form and the brief pain intensity questionnaire form will be completed by the patient. Patients in the control group will receive routine blood sugar control training. In the twelfth week of the visit, the pain assessment form will be provided to them again for completion. The diabetes indicators of the control group patients will be measured and recorded in the same time intervals and exactly at the same time of the day and night (similar to the intervention group), pain and disease symptoms for 12 weeks as the first appointment (first session) and after 12 weeks. Then the results will be compared in two intervention and control groups.Also, after conducting the research in order to comply with the ethical points and if the patients wish, all the cases done for the intervention group will be provided to the patients of the control group in the form of a CD.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Beheshte Tabarsi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>The end of Shahid Sattari highway, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1916893813</zip>
        <telephone>+98 21 2200 4355</telephone>
        <email>btabarsi@iautmu.ac.ir</email>
        <affiliation>Faculty of Nursing and Midwifery, Azad University of Medical Sciences, Tehran</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Beheshte Tabarsi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>The end of Shahid Sattari highway, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1916893813</zip>
        <telephone>+98 21 2200 4355</telephone>
        <email>btabarsi@iautmu.ac.ir</email>
        <affiliation>Faculty of Nursing and Midwifery, Azad University of Medical Sciences, Tehran</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>People who have HbA1C below 9 (under control of disease complications).
Fasting blood sugar should be above 126 and blood sugar two hours after eating should be above 200.
Symptoms of leg tingling, constant burning pain, and at the same time constant numbness, and the diagnosis of neuropathy has been given by the attending physician.
Have the ability to do foot exercises.</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Unwillingness to continue cooperation.
Unfavorable clinical condition of the patient (such as hypoglycemia during exercise that leads to hospitalization of the patient).</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E00–E90</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Endocrine, nutritional and metabolic diseases</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention group, after selecting the qualified samples and explaining about the research stages, the required concepts and the benefits of leg exercises and how to perform them, the patient's consent is obtained, and then after obtaining a written consent, in the same session, the personal information form and the questionnaire A summary of the pain intensity will be provided to the patient and after going through the above steps, for 12 consecutive weeks and three days a week between 8:00 and 13:00, one training set with 8-10 repetitions per hour individually for each person, in the bed. The patient performs leg exercises in the presence of the researcher, which will take 5-10 minutes. At home, these exercises should be performed 2-3 times a day, 10 repetitions each time, and the number of times will gradually increase, and the patients will be monitored and guided by phone calls at least once a week.Before and after performing leg exercises (before the intervention and then 12 weeks later), the patient's diabetes indicators (glycosylated hemoglobin, fasting blood sugar, blood sugar 2 hours after a meal and body mass index) are measured and recorded. Also, before and after the completion of 12 weeks, the patient's pain level is measured by a questionnaire.</i_keyword>
      <i_keyword>Control group: In the control group, the patient's consent will be obtained after the necessary explanations about the research steps. Then, in the same meeting, the personal information form and the brief pain intensity questionnaire form will be completed by the patient. Patients in the control group will receive routine blood sugar control training. In the twelfth week of the visit, the pain assessment form will be provided to them again for completion. The diabetes indicators of the control group patients will be measured and recorded in the same time intervals and exactly at the same time of the day and night (similar to the intervention group), pain and disease symptoms for 12 weeks as the first appointment (first session) and after 12 weeks. Then the results will be compared in two intervention and control groups.Also, after conducting the research in order to comply with the ethical points and if the patients wish, all the cases done for the intervention group will be provided to the patients of the control group in the form of a CD.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Diabetic neuropathy pain. Timepoint: Before and after the intervention of foot exercises. Method of measurement: Brief standardized pain intensity questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Faculty of Medicine, Islamic Azad University of Medical Sciences, Tehran</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-04-26</approval_date>
        <contact_name>کمیته اخلاق دانشکده پزشکی دانشگاه علوم پزشکی آزاد اسلامی تهران</contact_name>
        <contact_address>تهران، خیابان شریعتی، خیابان خاقانی Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
